Recent Posts

May 17th, 2009

Podcast 43: An interview with Martha Gulati on her research into the cardiovascular risks faced by symptomatic women who have normal angiograms.

Northwestern’s Martha Gulati has just published a paper in Archives of Internal Medicine about the hazards of treating symptomatic women with normal angiograms as if they had a benign prognosis.

We’ll talk with her after a look at the news, and a reminder that you can really help Clinical Conversations with your feedback. The place to call with suggestions is 1-617-440-4374.

This week’s links:

Interview link:

May 8th, 2009

Podcast 42: An interview with Danielle Ofri — author, editor, clinician.


We talk about writing with Danielle Ofri, editor of the Bellevue Literary Review, author of “Singular Intimacies: Becoming a Doctor at Bellevue” and “Incidental Findings: Lessons from My Patients in the Art of Medicine,” and an attending physician at Bellevue.

I figured you could do with less information about influenza. If you’ve got a reaction, call us at 1-617-440-4374 and share it.

This week’s links:

May 4th, 2009

Podcast 41: A repeat of an interview with Dr. Anne Schuchat of the CDC on childhood immunization levels.

Your host is struggling with an overload of pollen and its attendant insults to his immune system. Or maybe it’s the dreaded swine flu. In any event, Dr. Anne Schuchat gave an interesting interview on childhood immunization levels in those halcyon pre-porcine-obsessed days of September 2008, and I’m repeating it for you this week.

This week’s links:

  • Resources mentioned in the interview with Dr. Schuchat:
  1. http://www.cdc.gov/vaccines/
  2. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5735a1.htm

April 25th, 2009

Podcast 40: Tight control in type 2 diabetes — time to loosen up? A conversation with Mayo’s Victor Montori.

The Annals of Internal Medicine published an intriguing essay online last week about tight glycemic control in type 2 diabetes. Its authors argue that we’ve got it all wrong: imposing tight controls is only subjecting patients to stresses — related to the complexities and costs of treatment — that make control less likely to succeed. In addition, the supposed benefits of that control haven’t been confirmed by the available evidence. They advocate a backing-off of the current stern limits, which might make visits to clinicians feel less like a visit to the principal’s office. Listen in on a conversation with Dr. Victor Montori, one of the essay’s coauthors.

As always, you are invited to weigh in with your own thoughts. Leave us a piece of your mind at 1-617-440-4374.

This week’s links:

April 20th, 2009

Podcast 39: A conversation with Kimford Meador about a new paper assessing the later cognitive effects of fetal exposure to antiepileptic drugs.

Neurologists have talked about these effects for a while, but now they’ve got evidence showing that valproate lowers IQ at age 3 by almost 10 points. Since only half the antiepileptics are used in epilepsy, the results will affect everyone caring for women of reproductive age. Kimford Meador of Emory University is here to talk with us about it.

Let me have your reactions at 1-617-440-4370. I do like hearing from listeners, if only to guide me to better content.

This week’s news and interview links:

April 11th, 2009

Podcast 38: A conversation about using PPIs in poorly controlled asthma — rather, not using them — with Robert A. Wise of Johns Hopkins.

There are lots of people with poorly controlled asthma who are on PPIs, but don’t need to be. That’s the clear implication of research just published in the New England Journal of Medicine. We’ll talk with a member of the writing committee, Dr. Robert A. Wise.

If you like what you hear, call 1-617-440-4374, and if you don’t, the number’s the same — call anyway.

Here are the principal links for this week’s podcast:

Clinical Conversations

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.

Follow us:
Follow on Apple Podcasts

Listen on Youtube

Follow on Spotify